SAN MATEO, Calif. – Evidation Health has raised $30 million in Series C funding in a round co-led by SV Health Investors and B Capital Group.
The company has also launched a new data platform that allows customers to analyze and process large-scale sensor and behavior data in clinically meaningful ways, said Deborah Kilpatrick, CEO of Evidation Health, in a statement.
“Our new data platform makes it easier for statisticians and data scientists at life sciences and health care companies to take everyday behavior and health care data, analyze it, and create a new understanding of health,” she said. “This will help Evidation speed a transformation in real world research and knowledge, so we can better treat, diagnose, and predict the onset of disease.”
By linking real world data from smartphones and connected sensors—including wearables and medical devices—with traditional medical data, Evidation measures how behaviors outside of the doctor’s office or hospital relate to health and impact outcomes, Kilpatrick said.
The new platform can process data from more than 100 sources, including Apple Health, Fitbit, Epic, Blue Button and Dexcom. It currently processes more than 1 trillion data points each year across millions of individuals, and is being used in the areas of diabetes, cognitive decline, cardiovascular disease, chronic pain, asthma and more.
In addition to supporting the new data platform, the funding will also be used to develop partnerships, and to launch research studies to better understand and measure how everyday behavior and health interact, said Kilpatrick.
“Evidation’s ability to link patient behavior to medical outcomes is truly revolutionary and will help transform how we measure health in everyday life,” said Raj Ganguly, co-founder and partner of B Capital Group, in a statement.
Since 2012, Evidation Health has built a virtual pool of more than 2 million research participants through its Achievement app.